Our Research Publications
Updated November 2023
Pagination
- Previous page
- Page 35
- Next page
Title | Authors | Year | Journal | Link to Article | Intended Audience Sort descending | Purpose |
---|---|---|---|---|---|---|
The association of ABO blood group with indices of disease severity and multiorgan dysfunction in COVID-19 | Hoiland RL, Fergusson NA, Mitra AR, Griesdale DEG, Devine DV, Stukas S, Cooper J, Thiara S, Foster D, Chen LYC, Lee AYY, Conway EM, Wellington CL, Sekhon MS | 2020 | Blood Adv | View The association of ABO blood group with indices of disease severity and multiorgan dysfunction in COVID-19 | Health care providers | Clinical research |
Frequency and timing of all-cause deaths in visits involving suspected transfusion reactions, and the significance of cardiopulmonary disturbances | McVey MJ, Cohen R, Arsenault V, Escorcia A, Tasmin F, Pendergrast J, Lieberman L, Lin Y, Callum J, Cserti-Gazdewich C | 2021 | Vox Sang | View Frequency and timing of all-cause deaths in visits involving suspected transfusion reactions, and the significance of cardiopulmonary disturbances | Health care providers | Clinical research |
Vox Sanguinis International forum on the selection and preparation of blood components for intrauterine transfusion | Clarke G, Bodnar M, Lozano M, Nadarajan VS, Lee C, Baud D, Canellini G, Gleich-Nagel T, Torres OW, Rey PL, Bub CB, Kutner JM, Castilho L, Saifee NH, Delaney M, Nester T, Wikman A, Tiblad E, Pierelli L, Matteocci A, Maresca M, Maisonneuve E, Cortey A, Jouannic J-M, Fornells J, Albersen A, de Haas M, Oepkes D, Lieberman L | 2020 | Vox Sang | View Vox Sanguinis International forum on the selection and preparation of blood components for intrauterine transfusion | Health care providers | Benchmarking and standard setting |
Directive no 343 réaffirmée : Prédiction du génotype RHD fœtal par test prénatal non invasif de routine | Johnson J-A, MacDonald K, Clarke G, Skoll A | 2022 | J Obstet Gynaecol Can | View Directive no 343 réaffirmée : Prédiction du génotype RHD fœtal par test prénatal non invasif de routine | Health care providers | Benchmarking and standard setting |
Validation of a flow-cytometry-based red blood cell antigen phenotyping method | Liwski R, Clarke G, Cheng C, Abidi SSR, Abidi SR, Quinn JG | 2023 | Vox Sang | View Validation of a flow-cytometry-based red blood cell antigen phenotyping method | Health care providers | New or improved product or process |
A benchmarking program to reduce red blood cell outdating: implementation, evaluation, and a conceptual framework | Barty RL, Gagliardi K, Owens W, Lauzon D, Scheuermann S, Liu Y, Wang G, Pai M, Heddle NM | 2015 | Transfusion | View A benchmarking program to reduce red blood cell outdating: implementation, evaluation, and a conceptual framework | Health care providers | Benchmarking and standard setting |
Circular of Information for the use of human blood components: Platelets | Jenkins C | 2017 | Blood.ca website | View Circular of Information for the use of human blood components: Platelets | Health care providers | Benchmarking and standard setting |
Donner au suivant : pourquoi nous avons besoin que VOUS donniez du sang | Callum J | 2017 | Blood.ca website | View Donner au suivant : pourquoi nous avons besoin que VOUS donniez du sang | Health care providers | Other |
Evaluation of the appropriateness of frozen plasma usage after introduction of prothrombin complex concentrates: a retrospective study | Shih AW, Kolesar E, Ning S, Manning N, Arnold DM, Crowther MA | 2015 | Vox Sang | View Evaluation of the appropriateness of frozen plasma usage after introduction of prothrombin complex concentrates: a retrospective study | Health care providers | New or improved product or process |
Hemoglobin C in a patient with sickle cell anemia: Transfusion-acquired SC disease | Estey MP, Capote KR, Barakauskas VE, Clarke G, Higgins T | 2015 | Clin Biochem | View Hemoglobin C in a patient with sickle cell anemia: Transfusion-acquired SC disease | Health care providers | Clinical research |
Management of immune-mediated thrombocytopenia | Arnold DM, Nazi I, Smith JW, Warkentin TE | 2016 | Rossi's Principles of Transfusion Medicine | View Management of immune-mediated thrombocytopenia | Health care providers | Clinical research |
Missed opportunities for prevention of perinatal transmission of hepatitis B: a retrospective cohort study | van Schalkwyk J, Nourmoussavi M, Massey A, Gustafson R, Brodkin E, Petric M, Krajden M, Dobson S, Buxton J, Bigham M, Pick N, Schreiber R, Sherlock CH, Money D, Yoshida EM | 2014 | Can J Gastroenterol Hepatol | View Missed opportunities for prevention of perinatal transmission of hepatitis B: a retrospective cohort study | Health care providers | Clinical research |
New cancers after autotransplantations for multiple myeloma | Mahindra A, Raval G, Mehta P, Brazauskas R, Zhang MJ, Zhong X, Bird JM, Freytes CO, Hale GA, Herzig R, Holmberg LA, Kamble RT, Kumar S, Lazarus HM, Majhail NS, Marks DI, Moreb JS, Olsson R, Saber W, Savani BN, Schiller GJ, Tay J, Vogl DT, Waller EK, Wiernik PH, Wirk B, Lonial S, Krishnan AY, Dispenzieri A, Brandenburg NA, Gale RP, Hari PN | 2015 | Biol Blood Marrow Transplant | View New cancers after autotransplantations for multiple myeloma | Health care providers | Clinical research |
Risk infection to spare bleeding? The quandary of splenectomy for immune thrombocytopenia | Zeller M, Arnold DM | 2015 | Am J Hematol | View Risk infection to spare bleeding? The quandary of splenectomy for immune thrombocytopenia | Health care providers | Clinical research |
Using pharmacokinetics to individualize hemophilia therapy | Iorio A | 2017 | Hematology Am Soc Hematol Educ Program | View Using pharmacokinetics to individualize hemophilia therapy | Health care providers | Clinical research |
Within-individual mean corpuscular volume variation | Cembrowski G, Topping K, Clarke G | 2014 | Arch Pathol Lab Med | View Within-individual mean corpuscular volume variation | Health care providers | Other |
Signalement des réactions transfusionnelles indésirables | Chargé S, Young D | 2018 | Blood.ca website | View Signalement des réactions transfusionnelles indésirables | Health care providers | Other |
Concentrates for Hemostatic Disorders and Hereditary Angioedema | Poon MC, Goodyear MD, Rydz N, Lee A | 2018 | Clinical Guide to Transfusion | View Concentrates for Hemostatic Disorders and Hereditary Angioedema | Health care providers | Other |
Rh System: Anti-V | Meunier D, Peng S, Clarke G | 2019 | Blood.ca website | View Rh System: Anti-V | Health care providers | Benchmarking and standard setting |
Circulaire d'information utilisation de composants sanguins humains: Composants plasmatiques | Stewart T | 2022 | Blood.ca website | View Circulaire d'information utilisation de composants sanguins humains: Composants plasmatiques | Health care providers | Benchmarking and standard setting |
Concentré de recherche: L’administration d’albumine par voie intraveineuse ne conduit pas à de meilleurs résultats chez les personnes subissant des opérations cardiaques | Bartoszko J | 2021 | Blood.ca website | View Concentré de recherche: L’administration d’albumine par voie intraveineuse ne conduit pas à de meilleurs résultats chez les personnes subissant des opérations cardiaques | Health care providers | Clinical research |
An online immunohematology educational resource for post-graduate hematology trainees: LearnSerology.ca | Arsenault V, Yan MTS, Tait G, Lewin A, Pendergrast J | 2023 | Transfus Apher Sci | View An online immunohematology educational resource for post-graduate hematology trainees: LearnSerology.ca | Health care providers | Education research |
Transfusion of a platelet pool contaminated with exotoxin-producing Staphylococcus aureus: a case report | Chi SI, Kumaran D, Zeller MP, Ramirez-Arcos S | 2022 | Annals of Blood | View Transfusion of a platelet pool contaminated with exotoxin-producing Staphylococcus aureus: a case report | Health care providers | Clinical research |
Emicizumab state-of-the-art update | Mahlangu J, Iorio A, Kenet G | 2022 | Haemophilia | View Emicizumab state-of-the-art update | Health care providers | Clinical research |
How do I/we forecast tomorrows’ transfusion: Blood components | Pereyra N, Devine DV | 2023 | Transfus Clin Biol | View How do I/we forecast tomorrows’ transfusion: Blood components | Health care providers | New or improved product or process |
A Guide to Reporting Adverse Transfusion Events | Canadian Blood Services | 2014 | Blood.ca website | View A Guide to Reporting Adverse Transfusion Events | Health care providers | Other |
ABO zygosity, but not secretor or Fc receptor status, is a significant risk factor for IVIG-associated hemolysis | Branch DR, Hellberg Å, Bruggeman CW, Storry JR, Sakac D, Blacquiere M, Tong TN, Burke-Murphy E, Binnington B, Parmar N, Riden LS, Willie K, Armali C, Aziz J, Lieberman L, Laroche V, Callum J, Lin Y, Shehata N, Pavenski K, Lau W, Hannach B, Kuijpers TW, Olsson ML, Cserti-Gazdewich C, Pendergrast J | 2018 | Blood | View ABO zygosity, but not secretor or Fc receptor status, is a significant risk factor for IVIG-associated hemolysis | Health care providers | Clinical research |
Association of blood donor age and sex with recipient survival after red blood cell transfusion | Chassé M, Tinmouth A, English SW, Acker JP, Wilson K, Knoll G, Shehata N, Van Walraven C, Forster A, Ramsay T, McIntyre L, Fergusson DA | 2016 | JAMA Intern Med | View Association of blood donor age and sex with recipient survival after red blood cell transfusion | Health care providers | Clinical research |
Blood and clots quizlet 4: Antithrombotic Therapy for Atrial Fibrillation | Tseng E, Shih A, de Wit K, Chan T | 2017 | CanadiEM website | View Blood and clots quizlet 4: Antithrombotic Therapy for Atrial Fibrillation | Health care providers | Benchmarking and standard setting |
Exposure to ABO-nonidentical blood associated with increased in-hospital mortality in patients with group A blood | Pai M, Cook R, Barty R, Eikelboom J, Lee KA, Heddle N | 2016 | Transfusion | View Exposure to ABO-nonidentical blood associated with increased in-hospital mortality in patients with group A blood | Health care providers | Clinical research |
Molecular immunohematology at Canadian Blood Services: red cell antigen genotyping | Goldman M, Hannaford K, Hannon J, Berardi P | 2016 | Blood.ca website | View Molecular immunohematology at Canadian Blood Services: red cell antigen genotyping | Health care providers | Other |
Perioperative transfusion-related acute lung injury: The Canadian Blood Services experience | Alam A, Huang M, Yi Q-L, Lin Y, Hannach B | 2014 | Transfus Apher Sci | View Perioperative transfusion-related acute lung injury: The Canadian Blood Services experience | Health care providers | Other |
Platelet transfusion: a systematic review of the clinical evidence | Kumar A, Mhaskar R, Grossman BJ, Kaufman RM, Tobian AA, Kleinman S, Gernsheimer T, Tinmouth AT, Djulbegovic B | 2015 | Transfusion | View Platelet transfusion: a systematic review of the clinical evidence | Health care providers | Clinical research |
Problems with precaution: the transfusion medicine experience | Wilson K, Atkinson KM, Fergusson DA, Brown A, Forster A, Murphy MS, Tinmouth AT, Keelan J | 2017 | J Risk Res | View Problems with precaution: the transfusion medicine experience | Health care providers | Ethical, legal and social implications research |
Routine nucleic acid testing of blood donations fails to detect all human immunodeficiency virus–positive blood donors | Fearon M, Scalia V, Lane D, Bigham M, Hawes G, O'Brien S, Kadkhoda K | 2016 | Transfusion | View Routine nucleic acid testing of blood donations fails to detect all human immunodeficiency virus–positive blood donors | Health care providers | Clinical research |
Therapeutic Apheresis | Pavenski K | 2014 | Clinical Guide to Transfusion | View Therapeutic Apheresis | Health care providers | Benchmarking and standard setting |
Transfusion-related acute lung injury (TRALI) | Petraszko T | 2017 | Blood.ca website | View Transfusion-related acute lung injury (TRALI) | Health care providers | Other |
Transfusion Safety: The Nature and Outcomes of Errors in Patient Registration | Cohen R, Ning S, Yan MTS, Callum J | 2018 | Transfus Med Rev | View Transfusion Safety: The Nature and Outcomes of Errors in Patient Registration | Health care providers | Clinical research |
Performing and interpreting individual pharmacokinetic profiles in patients with Hemophilia A or B: Rationale and general considerations | Iorio A, Edginton AN, Blanchette V, Blatny J, Boban A, Cnossen M, Collins P, Croteau SE, Fischer K, Hart DP, Ito S, Korth-Bradley J, Lethagen S, Lillicrap D, Makris M, Mathôt R, Morfini M, Neufeld EJ, Spears J | 2018 | Res Pract Thromb Haem | View Performing and interpreting individual pharmacokinetic profiles in patients with Hemophilia A or B: Rationale and general considerations | Health care providers | Clinical research |
A case of recurrent transfusion-related acute lung injury despite lessons learned from antibody mitigation | McVey MJ, Lin Y, Young DK, Cserti-Gazdewich C | 2019 | Transfus Med | View A case of recurrent transfusion-related acute lung injury despite lessons learned from antibody mitigation | Health care providers | Clinical research |
International Forum on Mitigation Strategies to Prevent Faint and Pre-faint Adverse Reactions in Whole Blood Donors: Responses | Goldman M, Townsend M, Magnussen K, Lozano M, Nissen-Meyer LSH, Lee CK, Leung JN, Takanashi M, McKay J, Kvist M, Robitaille N, Deschênes J, Di Angelantonio E, McMahon A, Roberts D, Maghsudlu M, Castrén J, Tiberghien P, Woimant G, Morel P, Kamel H, Bravo M, Shinar E, Gendelman V, Raz H, Wendel S, Fachini R, Quee F, van den Hurk K, Wiersum J, Grima KM, Speedy J, Bruun MT, Dunbar NM | 2021 | Vox Sang | View International Forum on Mitigation Strategies to Prevent Faint and Pre-faint Adverse Reactions in Whole Blood Donors: Responses | Health care providers | Benchmarking and standard setting |
Phenotype matching and storage age of blood for sickle cell patients: A review and recommendations for transfusion practice | Morin P-A, Skeate R, Clarke G | 2020 | Blood.ca website | View Phenotype matching and storage age of blood for sickle cell patients: A review and recommendations for transfusion practice | Health care providers | Benchmarking and standard setting |
The unique characteristics of COVID-19 coagulopathy | Iba T, Levy J, Conors J, Warkentin T, Tachil J, Levi M | 2020 | Crit Care | View The unique characteristics of COVID-19 coagulopathy | Health care providers | Clinical research |
Definition of a critical bleed in patients with immune thrombocytopenia: Communication from the ISTH SSC Subcommittee on Platelet Immunology | Sirotich E, Guyatt G, Gabe C, Ye Z, Beck CE, Breakey V, Cooper N, Cuker A, Charness J, de Wit K, DiRaimo J, Fein SG, Grace RF, Hassan Z, Jamula E, Kang M, Manski CF, O'Connor C, Pai M, Paynter D, Porter SC, Pruitt B, Strachan G, Webert KE, Yan JW, Kelton JG, Bakchoul T, Arnold DM | 2021 | J Thromb Haemost | View Definition of a critical bleed in patients with immune thrombocytopenia: Communication from the ISTH SSC Subcommittee on Platelet Immunology | Health care providers | Benchmarking and standard setting |
Réactions transfusionnelles anaphylactiques et déficit en IgA | Khandelwal A, Clarke G, Goldman M | 2021 | Blood.ca website | View Réactions transfusionnelles anaphylactiques et déficit en IgA | Health care providers | Benchmarking and standard setting |
Factors associated with wrong blood in tube errors: An international case series - The BEST collaborative study | Dunbar NM, Kaufman RM | 2021 | Transfusion | View Factors associated with wrong blood in tube errors: An international case series - The BEST collaborative study | Health care providers | Benchmarking and standard setting |
International Society of Blood Transfusion survey of experiences of blood banks and transfusion services during the COVID-19 pandemic | Al-Riyami AZ, Burnouf T, Wood EM, Devine DV, Oreh A, Apelseth TO, Goel R, Bloch EM, van Den Berg K, Getshen M, Louw V, Ang AL, Lee CK, Rahimi-Levene N, Stramer SL, Vassallo R, Schulze TJ, Patidar GK, Pandey HC, Dubey R, Badawi M, Hindawi S, Meshi A, Matsushita T, Sorrentino E, Grubovic Rastvorceva RM, Bazin R, Vermeulen M, Nahirniak S, Tsang HC, Vrielink H, Triyono T, Addas-Carvalho M, He?imovi? A, Torres OW, Mutindu SM, Bengtsson J, Dominguez D, Sayedahmed A, Hanisa Musa R, Gautam B, Herczenik E, So-Osman C, the ISBT COVID-19 Convalescent Plasma Working Group | 2022 | Vox Sang | View International Society of Blood Transfusion survey of experiences of blood banks and transfusion services during the COVID-19 pandemic | Health care providers | Benchmarking and standard setting |
Transfusion-Transmitted Infections | Drews SJ, Dodd RY | 2022 | Practical Transfusion Medicine | View Transfusion-Transmitted Infections | Health care providers | Benchmarking and standard setting |
Transfusion camp: A retrospective study of self-reported impact on postgraduate trainee transfusion practice | Yeung KCY, Kapitany C, Chargé S, Callum J, Cserti-Gazdewich C, D'Empaire PP, Khandelwal A, Lieberman L, Lee C, Pavenski K, Pendergrast J, Shehata N, Hsia CC, Lavoie M, Murphy MF, Prokopchuk-Gauk O, Rahmani M, Trudeau J, Zeller MP, Lin Y | 2023 | Transfusion | View Transfusion camp: A retrospective study of self-reported impact on postgraduate trainee transfusion practice | Health care providers | Education research |
Acute megakaryoblastic transformation from essential thrombocythemia | Roshan TM, Rajput AB, Berardi P, Padmore R | 2017 | Hum Pathol | View Acute megakaryoblastic transformation from essential thrombocythemia | Health care providers | Clinical research |